Moving forward with evidence and controversies: the challenges of MDR-TB.
Chiang
Chen-Yuan
CY
Van Deun
Armand
A
Caminero
Jose A
JA
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery
D000904:Antibiotics, Antitubercular; D007538:Isoniazid; D012293:Rifampin